Assessment of Glycemia Risk Index and Standard Continuous Glucose Monitoring Metrics in a Real-World Setting of Exercise in Adults With Type 1 Diabetes: A Post-Hoc Analysis of the Type 1 Diabetes and Exercise Initiative

被引:1
作者
Morrison, Dale [1 ,2 ]
Vogrin, Sara [1 ]
Zaharieva, Dessi P. [3 ]
机构
[1] Univ Melbourne, St Vincents Hosp Melbourne, Dept Med, 4th Floor,Clin Sci Bldg,29 Regent St, Melbourne, Vic 3065, Australia
[2] St Vincents Hosp Melbourne, Dept Endocrinol & Diabet, Melbourne, Vic, Australia
[3] Stanford Univ, Dept Pediat, Div Pediat Endocrinol, Stanford, CA USA
来源
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY | 2024年
关键词
type; 1; diabetes; exercise; hypoglycemia; hyperglycemia; glycemia risk index; time in range;
D O I
10.1177/19322968241246458
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Standardized reporting of continuous glucose monitoring (CGM) metrics does not provide extra weighting for very high or very low glucose, despite their distinct clinical significance, and thus may underestimate glycemic risk in people with type 1 diabetes (T1D) during exercise. Glycemia Risk Index (GRI) is a novel composite metric incorporating clinician-validated extra weighting for glycemic extremes, which may provide a novel summary index of glycemia risk around exercise. Methods: Adults (>= 18 years) in the T1D EXercise Initiative study wore CGM and activity trackers for four weeks. For this analysis, exercise days were defined as 24 hours following >= 20 minutes of exercise, with no other exercise in the 24-hour period. Sedentary days were defined as any 24 hours with no recorded exercise within that period or the preceding 24 hours. Linear mixed-effects regression was used to evaluate exercise effects on GRI and CGM metrics within 24 hours postexercise. Results: In 408 adults with T1D with > 70% CGM and activity data, GRI on exercise (N = 3790) versus sedentary days (N = 1865) was significantly lower (mean [SD]: 29.9 [24.0] vs 34.0 [26.1], respectively, absolute mean difference -1.70 [-2.73, -0.67], P < .001), a similar to 5% reduction in glycemic risk. Percent time in range (TIR; 70-180 mg/dL) increased on exercise days (absolute mean difference 2.67 [1.83, 3.50], P < .001), as did time below range (TBR; relative mean difference 1.17 [1.12, 1.22], P < .001), while time above range (TAR) decreased (relative mean difference 0.84 [0.79, 0.88], P < .001). Conclusions: Glycemia Risk Index improved on exercise versus sedentary days, despite increased TBR, which is weighted most heavily in the GRI calculation, due to a robust reduction in TAR.
引用
收藏
页码:787 / 794
页数:8
相关论文
共 20 条
  • [1] Aleppo Grazia, 2021, Diabetes Spectr, V34, P109, DOI 10.2337/ds20-0093
  • [2] [Anonymous], 2017, ACSMs exercise testing and prescription
  • [3] Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
    Battelino, Tadej
    Danne, Thomas
    Bergenstal, Richard M.
    Amiel, Stephanie A.
    Beck, Roy
    Biester, Torben
    Bosi, Emanuele
    Buckingham, Bruce A.
    Cefalu, William T.
    Close, Kelly L.
    Cobelli, Claudio
    Dassau, Eyal
    DeVries, J. Hans
    Donaghue, Kim C.
    Dovc, Klemen
    Doyle, Francis J.
    Garg, Satish
    Grunberger, George
    Heller, Simon
    Heinemann, Lutz
    Hirsch, Irl B.
    Hovorka, Roman
    Jia, Weiping
    Kordonouri, Olga
    Kovatchev, Boris
    Kowalski, Aaron
    Laffel, Lori
    Levine, Brian
    Mayorov, Alexander
    Mathieu, Chantal
    Murphy, Helen R.
    Nimri, Revital
    Norgaard, Kirsten
    Parkin, Christopher G.
    Renard, Eric
    Rodbard, David
    Saboo, Banshi
    Schatz, Desmond
    Stoner, Keaton
    Urakami, Tatsuiko
    Weinzimer, Stuart A.
    Phillip, Moshe
    [J]. DIABETES CARE, 2019, 42 (08) : 1593 - 1603
  • [4] Choudhary P, 2022, LANCET DIABETES ENDO, V10, P720, DOI 10.1016/S2213-8587(22)00212-1
  • [5] Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
    Colberg, Sheri R.
    Sigal, Ronald J.
    Yardley, Jane E.
    Riddell, Michael C.
    Dunstan, David W.
    Dempsey, Paddy C.
    Horton, Edward S.
    Castorino, Kristin
    Tate, Deborah F.
    [J]. DIABETES CARE, 2016, 39 (11) : 2065 - 2079
  • [6] Time in Range for Closed-Loop Systems versus Standard of Care during Physical Exercise in People with Type 1 Diabetes: A Systematic Review and Meta-Analysis
    Eckstein, Max L.
    Weilguni, Benjamin
    Tauschmann, Martin
    Zimmer, Rebecca T.
    Aziz, Faisal
    Sourij, Harald
    Moser, Othmar
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
  • [7] Efficacy and safety of closed-loop insulin delivery versus sensor-augmented pump in the treatment of adults with type 1 diabetes: a systematic review and meta-analysis of randomized-controlled trials
    Fang, Z.
    Liu, M.
    Tao, J.
    Li, C.
    Zou, F.
    Zhang, W.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (03) : 471 - 481
  • [8] Changes in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with type 1 diabetes
    Karakus, Kagan E.
    Shah, Viral N.
    Klonoff, David
    Akturk, Halis K.
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (11) : 3144 - 3151
  • [9] Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality
    Kim, Ji Yoon
    Yoo, Jee Hee
    Kim, Jae Hyeon
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (12) : 883 - 892
  • [10] A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
    Klonoff, David C.
    Wang, Jing
    Rodbard, David
    Kohn, Michael A.
    Li, Chengdong
    Liepmann, Dorian
    Kerr, David
    Ahn, David
    Peters, Anne L.
    Umpierrez, Guillermo E.
    Seley, Jane Jeffrie
    Xu, Nicole Y.
    Nguyen, Kevin T.
    Simonson, Gregg
    Agus, Michael S. D.
    Al-Sofiani, Mohammed E.
    Armaiz-Pena, Gustavo
    Bailey, Timothy S.
    Basu, Ananda
    Battelino, Tadej
    Bekele, Sewagegn Yeshiwas
    Benhamou, Pierre-Yves
    Bequette, B. Wayne
    Blevins, Thomas
    Breton, Marc D.
    Castle, Jessica R.
    Chase, James Geoffrey
    Chen, Kong Y.
    Choudhary, Pratik
    Clements, Mark A.
    Close, Kelly L.
    Cook, Curtiss B.
    Danne, Thomas
    Doyle, Francis J., III
    Drincic, Angela
    Dungan, Kathleen M.
    Edelman, Steven V.
    Ejskjaer, Niels
    Espinoza, Juan C.
    Fleming, G. Alexander
    Forlenza, Gregory P.
    Freckmann, Guido
    Galindo, Rodolfo J.
    Gomez, Ana Maria
    Gutow, Hanna A.
    Heinemann, Lutz
    Hirsch, Irl B.
    Hoang, Thanh D.
    Hovorka, Roman
    Jendle, Johan H.
    [J]. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, : 1226 - 1242